Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated with percutaneous coronary intervention. -insights from the SWEDEHEART registry
Publication date: Available online 17 November 2026 Source: American Heart Journal Author(s): Mikolaj Skibniewski, Gorav Batra, Emmanouil Charitakis, Magnus Janzon, Lars O Karlsson, Moman A. Mohammad, Sammy Zwackman, Dimitrios Venetsanos, Joakim Alfredsson
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated with percutaneous coronary intervention. -insights from the SWEDEHEART registry. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326003194?dgcid=rss_sd_all
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated with percutaneous coronary intervention. -insights from the SWEDEHEART registry. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0002870326003194?dgcid=rss_sd_all
“Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated with percutaneous coronary intervention. -insights from the SWEDEHEART registry.” American Journal of Kidney Diseases.
@article{article3293,
title = {Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated with percutaneous coronary intervention. -insights from the SWEDEHEART registry},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326003194?dgcid=rss_sd_all}
}